Marukian Svetlana, Jones Christopher T, Andrus Linda, Evans Matthew J, Ritola Kimberly D, Charles Edgar D, Rice Charles M, Dustin Lynn B
Center for the Study of Hepatitis C, Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA.
Hepatology. 2008 Dec;48(6):1843-50. doi: 10.1002/hep.22550.
Hepatitis C virus (HCV) replicates primarily in the liver, but HCV RNA has been observed in association with other tissues and cells including B and T lymphocytes, monocytes, and dendritic cells. We have taken advantage of a recently described, robust system that fully recapitulates HCV entry, replication and virus production in vitro to re-examine the issue of HCV infection of blood cell subsets. The HCV replicase inhibitor 2'C-methyl adenosine was used to distinguish HCV RNA replication from RNA persistence. Whereas cell culture-grown HCV replicated in Huh-7.5 hepatoma cells, no HCV replication was detected in B or T lymphocytes, monocytes, macrophages, or dendritic cells from healthy donors. No blood cell subset tested expressed significant levels of Claudin-1, a tight junction protein needed for HCV infection of Huh-7.5 cells. A B cell line expressing high levels of Claudin-1, CD81, and scavenger receptor BI remained resistant to HCV pseudoparticle infection. We bypassed the block in HCV entry by transfecting HCV RNA into blood cell subsets. Transfected RNA was not detectably translated and induced high levels of interferon-alpha. Supernatants from HCV RNA-transfected macrophages inhibited HCV replication in Huh-7.5 cells.
We conclude that multiple blocks prevent blood cells from supporting HCV infection.
丙型肝炎病毒(HCV)主要在肝脏中复制,但已观察到HCV RNA与包括B和T淋巴细胞、单核细胞及树突状细胞在内的其他组织和细胞有关联。我们利用了一种最近描述的强大系统,该系统能在体外完全重现HCV的进入、复制及病毒产生过程,以重新审视血细胞亚群的HCV感染问题。HCV复制酶抑制剂2'-C-甲基腺苷被用于区分HCV RNA复制与RNA持续性。虽然细胞培养生长的HCV在Huh-7.5肝癌细胞中复制,但在健康供体的B或T淋巴细胞、单核细胞、巨噬细胞或树突状细胞中未检测到HCV复制。所测试的血细胞亚群均未表达高水平的Claudin-1,而Claudin-1是Huh-7.5细胞HCV感染所需的紧密连接蛋白。一种表达高水平Claudin-1、CD81和清道夫受体BI的B细胞系对HCV假病毒颗粒感染仍具抗性。我们通过将HCV RNA转染到血细胞亚群中来绕过HCV进入的障碍。转染的RNA未被检测到翻译,并诱导产生高水平的α干扰素。HCV RNA转染的巨噬细胞的上清液抑制了Huh-7.5细胞中的HCV复制。
我们得出结论,多种障碍阻止血细胞支持HCV感染。